ID: ALA3963334

Max Phase: Preclinical

Molecular Formula: C26H34N6O6S

Molecular Weight: 558.66

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1ccc(S(=O)(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2ccc(NC(=O)CCCNC(=N)N)cc2)C(=O)O)cc1

Standard InChI:  InChI=1S/C26H34N6O6S/c1-17-6-12-20(13-7-17)39(37,38)32-15-3-4-22(32)24(34)31-21(25(35)36)16-18-8-10-19(11-9-18)30-23(33)5-2-14-29-26(27)28/h6-13,21-22H,2-5,14-16H2,1H3,(H,30,33)(H,31,34)(H,35,36)(H4,27,28,29)/t21-,22-/m0/s1

Standard InChI Key:  VGNCAQNFUDPWNT-VXKWHMMOSA-N

Associated Targets(Human)

Integrin alpha-V/beta-1 222 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 558.66Molecular Weight (Monoisotopic): 558.2261AlogP: 1.16#Rotatable Bonds: 12
Polar Surface Area: 194.78Molecular Species: ZWITTERIONHBA: 6HBD: 6
#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 7#RO5 Violations (Lipinski): 3
CX Acidic pKa: 3.20CX Basic pKa: 12.06CX LogP: -0.38CX LogD: -0.38
Aromatic Rings: 2Heavy Atoms: 39QED Weighted: 0.13Np Likeness Score: -1.11

References

1. Reed NI, Tang YZ, McIntosh J, Wu Y, Molnar KS, Civitavecchia A, Sheppard D, DeGrado WF, Jo H..  (2016)  Exploring N-Arylsulfonyl-l-proline Scaffold as a Platform for Potent and Selective αvβ1 Integrin Inhibitors.,  (10): [PMID:27774126] [10.1021/acsmedchemlett.6b00196]

Source